Evidence map›Paper›PMID 38816435›Full record

ArticleScientific reports2024

Determination of cinnamaldehyde, thymol and eugenol in essential oils by LC-MS/MS and antibacterial activity of them against bacteria.

Zhi Li, Yan Li, Wenbo Cheng

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Isolation and characterization ofFrontiers in microbiology · 2025
    Article
  4. Article
  5. Life (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Zhi LiTianjin Guoke Medical Technology Development Co., LTD, Tianjin, 300399, China.
Yan LiTianjin Guoke Medical Technology Development Co., LTD, Tianjin, 300399, China.
Wenbo ChengTianjin Guoke Medical Technology Development Co., LTD, Tianjin, 300399, China. chengwb@sibet.ac.cn.

Funding

Key Technologies R&D Program of Guangdong Province 2022B0303030002Tianjin Key R&D Program 22YFYSHZ00140
6 · The paper itself

Abstract

Plant essential oils contain many secondary metabolites, some of which can effectively inhibit the growth of pathogenic microorganisms, so it is a very promising antibacterial agent. In this study, a qualitative and quantitative method based on high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) was developed for the simultaneous determination of three bioactive substances, cinnamaldehyde (CNM), thymol (THY), and eugenol (EUG), in the essential oils of plants. Necessary tests for linearity, limit of quantification, recovery, carryover contamination and precision of the method were carried out. Then, the antibacterial activity of 3 bioactive compounds against Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus) was evaluated by minimal inhibitory concentration and the synergistic antimicrobial effect. The results indicated that CNM, THY and EUG had good antibacterial activity. According to the results of fractional inhibitory concentration index (FICI), it is considered that CNM + THY and CNM + THY + EUG has obvious synergistic inhibitory effect on E. coli, and CNM + THY and CNM + EUG has obvious synergistic inhibitory effect on S. aureus. Finally, we analyzed the effect of the bioactive compounds on trace elements in bacteria and found significant changes in magnesium, calcium, copper and iron.

Indexed as

AcroleinAnti-Bacterial AgentsEscherichia coliEugenolMicrobial Sensitivity TestsOils, VolatileStaphylococcus aureusTandem Mass SpectrometryThymolChromatography, High Pressure LiquidChromatography, LiquidLiquid Chromatography-Mass SpectrometryAcroleinAnti-Bacterial AgentscinnamaldehydeEugenolOils, VolatileThymolEssential oilsHPLC–MS/MSSynergistic antimicrobialTrace metal

Identifiers

PMID38816435
PMCPMC11139912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.